Interview: Ray O'Neill, Managing Director, ESS Ltd
Mr. O’Neill, you have been managing director of this company for 17 years. How have you evolved the business over that period? ESS was founded in 1991, and I joined…
Address: Irish BioIndustry Association, Confederation House, 84-86 Lower Baggot Street, Dublin 2,Ireland
Tel: (01) 605 1500
Web: http://www.ibec.ie/
The Irish BioIndustry Association (IBIA) is the leading representative body for the Biotechnology Industry in Ireland, has over 50 member companies and is affiliated to IBEC. The main aim of IBIA is to promote, support and encourage the further development of the multinational and indigenous biotech sector in Ireland. IBIA achieves this by building and maintaining excellent relations and a positive profile with Government, public agencies, other representative organisations, international bodies and patient groups.
Mission Statement
To enhance the environment in Ireland for the development of a successful multinational and indigenous sector in biotechnology sector
Strategic ObjectivesTo ensure a regulatory regime exists which allows biotechnology companies to prosper and grow
To communicate effectively to all stakeholders the benefits of biotechnology to society.
To actively promote research and development in biotechnology and related sciences and partnerships between industry and third level.
To actively promote an educational infrastructure which will be supportive of the biotechnology sector.
To actively participate in the work of the biotechnology industry in the rest of the European Union.
To promote a business environment which will enhance the development of the biotech sector on the whole island of Ireland.
Mr. O’Neill, you have been managing director of this company for 17 years. How have you evolved the business over that period? ESS was founded in 1991, and I joined…
Mr. O’Neill, you have been managing director of this company for 17 years. How have you evolved the business over that period? ESS was founded in 1991, and I joined…
Mr. Moore, can you please introduce our readers to yourself and to SteriPack? SteriPack was founded in Clara, Ireland, in 1994. When I joined the organization 18 years ago, we…
Can you please introduce our readers to Deloitte Ireland and the firm’s life science practice? Brendan Jennings (BJ): Deloitte’s presence in Ireland dates back over one hundred years. We currently…
Can you please introduce yourself and Arthur Cox’s life science practice to our readers? I am a partner within the technology and life sciences group at Arthur Cox, and head…
Mr. Cooke, you joined Alkermes after the company acquired the Elan Drug Technologies (EDT) unit in 2011—a unit you headed for four years. Can you please begin by introducing yourself…
Mr. Somers, can you please introduce us to the Helsinn Group and its unique in-licensing model? Helsinn is a Swiss-based, private company owned by the Braglia family. The Braglias have…
Mylan embarked upon its first major international expansion program in 2007, after the acquisition of Merck KGaA’s generic medicines business. How has the organization subsequently evolved in the UK/Ireland market…
Mr. Keogh, you founded Millmount Healthcare in 1999. What was the vision behind the company? Prior to founding Millmount, I spent ten years in pharmaceutical manufacturing and contract packaging in…
Can you please introduce us to Dalkia? Pat Gilroy: Dalkia is a multinational company that operates in over 40 countries throughout the world and turns over 8Bn EUR annually. We…
Mr. Garrahy, can you please begin by introducing yourself and this production facility to our readers? I joined Rottapharm in 1998, when the organization decided to establish its Dublin production…
Mr. Moran, can you please begin with a brief introduction to Pharmachemical Ireland, its mission, and how it works to achieve its goals? Pharmachemical Ireland (PCI) is an industry…
See our Cookie Privacy Policy Here
